Andy Pickett

688 total citations
22 papers, 362 citations indexed

About

Andy Pickett is a scholar working on Neurology, Cellular and Molecular Neuroscience and Dermatology. According to data from OpenAlex, Andy Pickett has authored 22 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 4 papers in Dermatology. Recurrent topics in Andy Pickett's work include Botulinum Toxin and Related Neurological Disorders (22 papers), Neurological disorders and treatments (14 papers) and Hereditary Neurological Disorders (9 papers). Andy Pickett is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (22 papers), Neurological disorders and treatments (14 papers) and Hereditary Neurological Disorders (9 papers). Andy Pickett collaborates with scholars based in United States, United Kingdom and France. Andy Pickett's co-authors include Gary D. Monheit, Mark S. Nestor, Naveed Panjwani, Mitchell Wortzman, Glynis Ablon, Jeffrey S. Dover, Mark Greener, Andrew Judge, Stephen Dodd and Raymond L. Rosales and has published in prestigious journals such as Toxicon, Toxins and Dermatologic Surgery.

In The Last Decade

Andy Pickett

21 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andy Pickett United States	12	326	136	99	86	24	22	362
Steven Bellows United States	7	211 0.6×	86 0.6×	35 0.4×	25 0.3×	32 1.3×	12	251
Carl Swartling Sweden	11	180 0.6×	52 0.4×	210 2.1×	90 1.0×	2 0.1×	18	345
Michael Stanton United States	7	137 0.4×	64 0.5×	123 1.2×	15 0.2×	6 0.3×	11	245
Mafalda Castelão United Kingdom	7	210 0.6×	78 0.6×	39 0.4×	12 0.1×	3 0.1×	9	235
J. W. M. Brans Netherlands	9	392 1.2×	178 1.3×	42 0.4×	4 0.0×	9 0.4×	13	410
Yosef Berlyand United States	8	127 0.4×	45 0.3×	61 0.6×	5 0.1×	91 3.8×	17	272
Tetsuhiro Harakawa Japan	10	306 0.9×	151 1.1×	109 1.1×	3 0.0×	22 0.9×	14	336
Nicola Cooke United Kingdom	4	192 0.6×	14 0.1×	77 0.8×	13 0.2×	21 0.9×	4	255
Olga Orlova Russia	6	177 0.5×	62 0.5×	31 0.3×	10 0.1×	2 0.1×	35	208
Charulata Sankhla India	8	275 0.8×	107 0.8×	35 0.4×	3 0.0×	15 0.6×	15	312

Countries citing papers authored by Andy Pickett

Since Specialization

Citations

This map shows the geographic impact of Andy Pickett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Pickett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Pickett more than expected).

Fields of papers citing papers by Andy Pickett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Pickett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Pickett. The network helps show where Andy Pickett may publish in the future.

Co-authorship network of co-authors of Andy Pickett

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Pickett. A scholar is included among the top collaborators of Andy Pickett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Pickett. Andy Pickett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monheit, Gary D. & Andy Pickett. (2017). AbobotulinumtoxinA: A 25-Year History. Aesthetic Surgery Journal. 37(suppl_1). S4–S11. 37 indexed citations

Nestor, Mark S., Glynis Ablon, & Andy Pickett. (2017). Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration. Aesthetic Surgery Journal. 37(suppl_1). S20–S31. 40 indexed citations

Dover, Jeffrey S., Gary D. Monheit, Mark Greener, & Andy Pickett. (2017). Botulinum Toxin in Aesthetic Medicine: Myths and Realities. Dermatologic Surgery. 44(2). 249–260. 47 indexed citations

Nestor, Mark S., et al.. (2017). The Use of Botulinum Neurotoxin Type A in Aesthetics: Key Clinical Postulates. Dermatologic Surgery. 43(3). S344–S362. 11 indexed citations

Pickett, Andy. (2015). Historical aspects of botulinum toxin used clinically: part II: overcoming resistance. 3(1). 34–34. 1 indexed citations

Rzany, Berthold, Alina Fratila, Tanja Fischer, et al.. (2013). Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.. PubMed. 12(1). 80–4. 12 indexed citations

Pickett, Andy. (2013). Historical aspects of botulinum toxin used clinically: Part I: is that the right serotype?. 2(3/4). 176–176. 2 indexed citations

Pickett, Andy. (2012). Inability of Speculation to Explain Dose Effect Differences Between Botulinum Toxin Products. Archives of Facial Plastic Surgery. 14(6). 467–468.

Pickett, Andy & Raymond L. Rosales. (2011). New Trends in the Science of Botulinum Toxin-A as Applied in Dystonia. International Journal of Neuroscience. 121(sup1). 22–34. 8 indexed citations

10.

Pickett, Andy. (2011). Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data. Clinical ophthalmology. 5. 1287–1287. 1 indexed citations

11.

Pickett, Andy, et al.. (2011). Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool. Toxins. 3(1). 63–81. 25 indexed citations

12.

Pickett, Andy. (2011). Comment on "The Botulinum Neurotoxin LD50 Test - Problems and Solutions". ALTEX. 2 indexed citations

13.

Pickett, Andy. (2010). Re-Engineering Clostridial Neurotoxins for the Treatment of Chronic Pain. BioDrugs. 24(3). 173–182. 15 indexed citations

14.

Pickett, Andy, et al.. (2010). Formulation composition of botulinum toxins in clinical use.. PubMed. 9(9). 1085–91. 16 indexed citations

15.

Pickett, Andy. (2009). Dysport®: Pharmacological properties and factors that influence toxin action. Toxicon. 54(5). 683–689. 45 indexed citations

16.

Wortzman, Mitchell & Andy Pickett. (2009). The Science and Manufacturing Behind Botulinum Neurotoxin Type A-ABO in Clinical Use. Aesthetic Surgery Journal. 29(6). S34–S42. 25 indexed citations

17.

Huber, Alexander, Richard M. France, Helen M. Cox, et al.. (2008). The Intercostal NMJ Assay — A New Alternative to the Conventional LD50 Assay for the Determination of the Therapeutic Potency of Botulinum Toxin Preparations. Alternatives to Laboratory Animals. 36(2). 141–152. 8 indexed citations

18.

Pickett, Andy, et al.. (2008). The in vivo rat muscle force model is a reliable and clinically relevant test of consistency among botulinum toxin preparations. Toxicon. 52(3). 455–464. 20 indexed citations

19.

Pickett, Andy. (2008). On the discovery of Bacillus botulinus. 1(1). 5–5. 2 indexed citations

20.

Panjwani, Naveed, et al.. (2008). Biochemical, functional and potency characteristics of type A botulinum toxin in clinical use. 1(1). 153–153. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact